Investment Summary

Novo Holdings A/S Invests In ConvaTec

On March 28, 2017, corporate investor Novo Holdings A/S invested in medical products company ConvaTec

Investment Highlights
  • This is Novo Holdings A/S’s 1st transaction in the Medical Products sector.
  • This is Novo Holdings A/S’s 1st transaction in the United Kingdom.

Investment Summary
Date 2017-03-28
Target ConvaTec
Sector Medical Products
Investor(s) Novo Holdings A/S
Deal Type Stake Purchase

Target

ConvaTec

Reading, United Kingdom
ConvaTec is a global medical products and technologies company that provides advanced wound care, ostomy care, continence, and critical care, and infusion devices. ConvaTec was formed in 1972 and is based in Reading, United Kingdom.

Search 200,197 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

Novo Holdings A/S

Investor Investor Investor Investor Investor

Category Corporate Investor
Founded 1999
Size Middle-Market
Type Sector Focused
DESCRIPTION

Novo Holdings A/S is a Danish holding company and the investment arm of the Novo Nordisk Foundation. Novo Holdings' objective is to grow the assets of the Foundation and improve the lives of people around the world. In addition to investing in equity and fixed income securities, Novo Holdings pursues direct investments in life science companies. Novo Holdings A/S was established in 1999 and is headquartered in Hellerup, Denmark.

DEAL STATS #
Overall 3 of 15
Sector (Medical Products) 1 of 2
Type (Stake Purchase) 1 of 1
Country (United Kingdom) 1 of 2
Year (2017) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-07-15 Sonion

Roskilde, Denmark

Sonion is a development, manufacturing, and sale of advanced micro acoustical and micromechanical components and solutions. The company is a B2B provider for global manufacturers of hearing instruments, mobile handsets, headsets, earphones, and medical devices. Sonion was formed in 1974 and is based in Roskilde, Denmark.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-11-14 WCG

Princeton, New Jersey, United States

WCG is a provider of regulatory and ethical review services for human research. The pioneer of independent ethical review, WCG continues to drive ingenuity in the clinical research space. WCG delivers transformational solutions that stimulate growth, foster compliance and maximize efficiency for those who perform clinical trials. WCG was founded in 2012 and is based in Princeton, New Jersey.

Buy -
Mergr

Product

Company

Legal